Research programme: G protein-coupled receptor modulators - Infinity Pharmaceuticals/AllerganAlternative Names: GPCR modulators - Infinity Pharmaceuticals/Allergan
Latest Information Update: 18 Jul 2007
At a glance
- Originator Allergan; Infinity Pharmaceuticals
- Mechanism of Action G protein-coupled receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Eye disorders; Neurological disorders
Most Recent Events
- 18 Jul 2007 Discontinued - Preclinical for Neurological disorders in USA (unspecified route)
- 18 Jul 2007 Discontinued - Preclinical for Eye disorders in USA (unspecified route)
- 13 Sep 2006 Discovery Partners International has been acquired and merged into Infinity Pharmaceuticals